These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 8739603

  • 21. Pathways of activation of the Epstein-Barr virus productive cycle.
    Sinclair AJ, Brimmell M, Shanahan F, Farrell PJ.
    J Virol; 1991 May; 65(5):2237-44. PubMed ID: 1850009
    [Abstract] [Full Text] [Related]

  • 22. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
    Gradoville L, Kwa D, El-Guindy A, Miller G.
    J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of mouse hepatitis virus multiplication by phosphorothioate analogues of oligodeoxynucleotides complementary to the leader RNA.
    Hayashi M, Maeda A, Watanabe T, Hanaki K, Arai S, Nozaki S.
    J Vet Med Sci; 1995 Dec; 57(6):1081-3. PubMed ID: 8720052
    [Abstract] [Full Text] [Related]

  • 24. Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBV.
    Brousset P, Drouet E, Schlaifer D, Icart J, Payen C, Meggetto F, Marchou B, Massip P, Delsol G.
    AIDS; 1994 May; 8(5):583-90. PubMed ID: 7914731
    [Abstract] [Full Text] [Related]

  • 25. Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1.
    Schepers A, Pich D, Hammerschmidt W.
    Virology; 1996 Jun 15; 220(2):367-76. PubMed ID: 8661388
    [Abstract] [Full Text] [Related]

  • 26. Mutations of amino acids in the DNA-recognition domain of Epstein-Barr virus ZEBRA protein alter its sub-nuclear localization and affect formation of replication compartments.
    Park R, Heston L, Shedd D, Delecluse HJ, Miller G.
    Virology; 2008 Dec 20; 382(2):145-62. PubMed ID: 18937960
    [Abstract] [Full Text] [Related]

  • 27. Latent and lytic Epstein-Barr virus replication strategies.
    Tsurumi T, Fujita M, Kudoh A.
    Rev Med Virol; 2005 Dec 20; 15(1):3-15. PubMed ID: 15386591
    [Abstract] [Full Text] [Related]

  • 28. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.
    Feng WH, Westphal E, Mauser A, Raab-Traub N, Gulley ML, Busson P, Kenney SC.
    J Virol; 2002 Nov 20; 76(21):10951-9. PubMed ID: 12368338
    [Abstract] [Full Text] [Related]

  • 29. EBV-immortalized isogenic human B-cell clones exhibit differences in DNA-protein complex formation on the BZLF1 and BRLF1 promoter regions among latent, lytic and TPA-activated cell lines.
    Cen H, McKnight JL.
    Virus Res; 1994 Jan 20; 31(1):89-107. PubMed ID: 8165871
    [Abstract] [Full Text] [Related]

  • 30. Latency of Epstein-Barr virus is stabilized by antisense-mediated control of the viral immediate-early gene BZLF-1.
    Prang N, Wolf H, Schwarzmann F.
    J Med Virol; 1999 Dec 20; 59(4):512-9. PubMed ID: 10534735
    [Abstract] [Full Text] [Related]

  • 31. Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function.
    Verma D, Thompson J, Swaminathan S.
    Proc Natl Acad Sci U S A; 2016 Mar 29; 113(13):3609-14. PubMed ID: 26976570
    [Abstract] [Full Text] [Related]

  • 32. Multiple roles of Epstein-Barr virus SM protein in lytic replication.
    Han Z, Marendy E, Wang YD, Yuan J, Sample JT, Swaminathan S.
    J Virol; 2007 Apr 29; 81(8):4058-69. PubMed ID: 17287267
    [Abstract] [Full Text] [Related]

  • 33. The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1.
    Su MT, Wang YT, Chen YJ, Lin SF, Tsai CH, Chen MR.
    J Virol; 2017 May 01; 91(9):. PubMed ID: 28228591
    [Abstract] [Full Text] [Related]

  • 34. Formation of intranuclear replication compartments of Epstein-Barr virus with redistribution of BZLF1 and BMRF1 gene products.
    Takagi S, Takada K, Sairenji T.
    Virology; 1991 Nov 01; 185(1):309-15. PubMed ID: 1656589
    [Abstract] [Full Text] [Related]

  • 35. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle.
    Evans TJ, Jacquemin MG, Farrell PJ.
    Virology; 1995 Feb 01; 206(2):866-77. PubMed ID: 7856099
    [Abstract] [Full Text] [Related]

  • 36. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression.
    Li Y, Webster-Cyriaque J, Tomlinson CC, Yohe M, Kenney S.
    J Virol; 2004 Apr 01; 78(8):4197-206. PubMed ID: 15047835
    [Abstract] [Full Text] [Related]

  • 37. Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus.
    Gutiérrez MI, Ibrahim MM, Dale JK, Greiner TC, Straus SE, Bhatia K.
    J Natl Cancer Inst; 2002 Dec 04; 94(23):1757-63. PubMed ID: 12464647
    [Abstract] [Full Text] [Related]

  • 38. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W, Iwakiri D, Yamamoto K, Maruo S, Kanda T, Takada K.
    J Virol; 2007 Jan 04; 81(2):1037-42. PubMed ID: 17079287
    [Abstract] [Full Text] [Related]

  • 39. Lytic cycle switches of oncogenic human gammaherpesviruses.
    Miller G, El-Guindy A, Countryman J, Ye J, Gradoville L.
    Adv Cancer Res; 2007 Jan 04; 97():81-109. PubMed ID: 17419942
    [Abstract] [Full Text] [Related]

  • 40. Epstein-Barr virus polymerase processivity factor enhances BALF2 promoter transcription as a coactivator for the BZLF1 immediate-early protein.
    Nakayama S, Murata T, Murayama K, Yasui Y, Sato Y, Kudoh A, Iwahori S, Isomura H, Kanda T, Tsurumi T.
    J Biol Chem; 2009 Aug 07; 284(32):21557-68. PubMed ID: 19491105
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.